Vapotherm. has been granted a patent for a respiratory therapy system featuring a base unit and an attachable auxiliary unit. The system utilizes non-contact couplings for efficient operation, including induction heating and capacitive sensing, to deliver heated and humidified breathing gas at high velocities through a nasal cannula. GlobalData’s report on Vapotherm gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Vapotherm Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Vapotherm, Wearable CPAP therapy was a key innovation area identified from patents. Vapotherm's grant share as of July 2024 was 49%. Grant share is based on the ratio of number of grants to total number of patents.

System for providing heated, humidified breathing gas therapy

Source: United States Patent and Trademark Office (USPTO). Credit: Vapotherm Inc

The granted patent US12064562B2 describes a respiratory therapy system designed to deliver heated and humidified breathing gas to patients. The system consists of a base unit and an attachable auxiliary unit, which includes a low-pressure blower with a pressure limit of less than 270 hPa. The blower can source breathing gas from various origins, including ambient air or wall outlets, and is connected to a humidifier that enhances the gas's moisture content. The humidifier features an internal reservoir for liquid, which is heated by a non-contact heat actuator using induction. This actuator generates heat in a plate within the reservoir, while a level sensor monitors the liquid's volume, ensuring optimal humidification. The system also includes a conduit that channels the humidified gas to a non-sealing nasal cannula, designed to deliver the gas at specific exit velocities and flow rates.

The nasal cannula's design is critical, with various configurations of inner diameters and flow setpoints specified to optimize performance. The system's controller and processor are programmed to receive data regarding the nasal cannula's dimensions and the gas flow rate, allowing for real-time calculations of exit velocity. Additionally, the system can adjust flow rates based on user input and monitor humidity levels by analyzing changes in liquid levels within the reservoir. This innovative approach aims to enhance the efficacy of respiratory therapy by providing precise control over the delivery of heated and humidified breathing gas, tailored to individual patient needs.

To know more about GlobalData’s detailed insights on Vapotherm, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.